Bacterial toxin may fuel colorectal cancer metastasis

A toxin in the bacteria that’s one of the most common causes of foodborne illness accelerates the spread of colorectal tumors to other parts of the body, a study led by UF Health Cancer Center researchers and international collaborators has found.

Bans on High-Capacity Magazines Tied to 91% Drop in Child Deaths in Mass Shootings

ORLANDO — Gun laws that banned the sale of large-capacity magazines had a meaningful impact on pediatric deaths associated with mass shootings, according to a

September 29, 2024

FDA approves Alvotech and Teva’s SELARSDI for new indications

SELARSDI, a human monoclonal antibody, targets the p40 protein found in interleukin (IL)-12 and IL-23 cytokines – key in immune-mediated diseases. Credit: BlurryMe/Shutterstock. The US

October 23, 2024

Cybin Launches Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder | Psychedelic Invest

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry platform company committed to revolutionizing mental healthcare by developing new and innovative

January 17, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.